The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125346271 12534627 1 I 20151010 20160628 20160706 20160706 EXP US-ABBVIE-16P-163-1669735-00 ABBVIE 71.00 YR M Y 0.00000 20160706 OT COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125346271 12534627 1 PS VIEKIRA PAK DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR 1 Oral UNKNOWN 206619
125346271 12534627 2 SS RIBAVIRIN. RIBAVIRIN 1 Oral UNKNOWN 0
125346271 12534627 3 SS RIBAVIRIN. RIBAVIRIN 1 Oral UNKNOWN 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125346271 12534627 1 Chronic hepatitis C
125346271 12534627 2 Chronic hepatitis C

Outcome of event

Event ID CASEID OUTC COD
125346271 12534627 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125346271 12534627 Anaemia
125346271 12534627 Anxiety
125346271 12534627 Asthenia
125346271 12534627 Balance disorder
125346271 12534627 Carotid artery occlusion
125346271 12534627 Confusional state
125346271 12534627 Deafness
125346271 12534627 Diarrhoea
125346271 12534627 Dizziness
125346271 12534627 Dyspnoea
125346271 12534627 Ear pain
125346271 12534627 Fall
125346271 12534627 Feeling cold
125346271 12534627 Headache
125346271 12534627 Herpes zoster
125346271 12534627 Increased tendency to bruise
125346271 12534627 Injection site pain
125346271 12534627 Insomnia
125346271 12534627 Jugular vein distension
125346271 12534627 Loss of consciousness
125346271 12534627 Muscle spasms
125346271 12534627 Nausea
125346271 12534627 Night blindness
125346271 12534627 Peripheral swelling
125346271 12534627 Rash
125346271 12534627 Stress
125346271 12534627 Urine analysis abnormal
125346271 12534627 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125346271 12534627 1 20150610 20151124 0
125346271 12534627 2 20150610 20150711 0
125346271 12534627 3 20150712 20151124 0